NEWS
11-04-2024: Exsure Private Limited joins the enhanced OIST Innovation Accelerator
15-01-2024 - 26.01.2024 : Exsure Private Limited earns coveted spot in OIST Innovation Startup Accelerator Bootcamp's Final TOP 12, set to undergo intensive entrepreneurship training and compete in a pitch event alongside global startups in January 2024.
After a competitive review and a rigorous 10-hour online entrepreneurship training at OIST Innovation Accelerator program, we are pleased to announce that EXSURE Private Limited has been selected in the Final TOP 12 for Stage 2 to participate in an intensive two-week OIST Innovation Startup Accelerator Bootcamp , to take place in January 2024 at the Okinawa Institute of Science and Technology on the beautiful island of Okinawa!
Over the next two-weeks, 12 promising startups from Japan 🇯🇵 Thailand 🇹🇭 Sweden 🇸🇪 India 🇮🇳 and Germany 🇩🇪 will go through an intense entrepreneurship training led by Frans Nauta, world renown coach to over 500 startups across 20+ countries.
This elite 12, selected from a larger applicant pool spanning 23 countries, will receive invaluable guidance on validating their ideas, crafting their value propositions, identifying target customers, and perfecting their pitches. At the end of this arduous bootcamp, they will compete head-to-head in a pitch event judged by expert technologists and investors.
01-01-2024 : Exsure PVT. LTD. has became a member of The Indian Extracellular Vesicles Society (IEVS)
ExSURE PVT. LTD. has became a member of The Indian Extracellular Vesicles Society (IEVS)
08.12.2023 : Exsure PVT. LTD. has been shortlisted in TOP 30 startups across 10+states in INDIA for Vignan Institute of Technology and Science VIGNAN-TBI IGNITION FUNDING
04.12.2023 - 06.12.2023: Exsure PVT. LTD. is attending #GLOBALBIOINDIA2023 from 4th-6th December 2023 at Bharat Mandapam, Pragati Maidan, New Delhi
01.12.2023 - 02.12.2023 : Exsure PVT. LTD. is attending 2ND edition of People's Festival of Innovations PFI 2023 at India International Centre, IIC New Delhi
01.12.2023 : Exsure has been featured in Forbes India
08.11.2023 : Exsure launches ready to use PBMC isolation reagent Leucosure from whole blood
Exsure launches ready to use PBMC isolation reagent Leucosure from whole blood
01.10.2023: 678P ExoDS: A bioengineered exosome-based capsule for targeted delivery of chemotherapy drugs to cancer cells and cancer stem cells
Our Abstract and Poster for ESMO - European Society for Medical Oncology Congress 2023 titled "ExoDS: A bioengineered exosome-based capsule for targeted delivery of chemotherapy drugs to cancer cells and cancer stem cells" has been published in Annals of Oncology.
https://www.annalsofoncology.org/article/S0923-7534(23)02701-1/fulltext
18.08.2023 : Exsure has successfully completed Herstart bootcamp organized by GUSEC
27-07-2023 Exsure's 1st Exosome Isolation Reagent Exosure is ready to use.
BOOK YOUR REAGENT here!
Email us: swastika.paul@exsure.in / abhishek.dutta@exsure.in
Contact:: 7980402341 / 7980457752
03-07-2023: Exsure secured the monthly allowance grant from Startup Odisha
26-06-2023: Exsure has secured a position in Top 100 startup Leap to Unicorn startups by IDFC FIRST BANK
We have secured position in the Top 100 startup Leap to Unicorn startups by IDFC FIRST BANK in association with Moneycontrol and CNBCTV18.
06-04-2023: Received Startup India Seed Fund
For More Details Please visit below Link.
https://www.startupindia.gov.in/startup-india-showcase#/profile/214
04-09-2022: Exsure secured a place in Top 20 premium startups in Odisha.
Exsure secured a place in Top 20 premium startups in Odisha. Got felicitated by Dr. Sanjukta Badhai and Dr. Omkar Rai in Fund stack 2.0 organized by Startup Odisha and AIC Nalanda.
27-08-2022: Secured 2nd position in Himalayan Startup Trek Challenge 2022 organized by IIT Mandi Catalyst.
26-08-2022: Secured a position in Top 15 in TIE Women Global Pitch Competition 2022
05-04-2022: MOU between EXSURE PVT LTD, & Cancer Centre, KIMS, Bhubaneswar
We feel happy to share that ExSURE PVT. LTD. signed an MOU with KALINGA INSTITUTE OF MEDICAL SCIENCES (PBMH, KIMS), Bhubaneswar, to validate the efficiency of our targeted drug-delivery platform in ex-vivo system.
We are extremely grateful to Prof. Dr. Bidhu Kalyan Mohanti (Director, KIMS Cancer Centre and HOD,Department of Radiation Oncology, PBMH, KIMS) and Dr Sabyasachi Parida (Senior Consultant, Surgical Oncology, PBMH, KIMS) and to the entire team of Medical Oncology, Surgical Oncology and Radiation Oncology for their constant support and guidance during this entire tenure.
Special thanks to KIIT-Technology Business Incubator for always being there throughout this journey of hardships!
